Finding effective treatment for cervix cancer is a tall order for contemporary scientists. Two vaccines have recently been developed that help protect women against contracting human Pappinola virus (“HPV”), a known factor in most cervical cancer cases.
Although precise causes of cervical cancer remain undetermined, prevailing medical consensus overwhelmingly indicates that early detection and accurate information about the signs and symptoms of cervical cancer drastically decreases its incidence.
Current medical protocol strongly suggests that all women over 30 years of age have an annual Pap Smear to check for carcinoma of cervix development. Patients whose test results are normal for three consecutive years and have no family history of cervical carcinoma may be tested only once every three years. In addition, experts advise women between the ages of 21 and 30 who are more likely to maintain active sex lives be tested annually, due to higher associated HPV risks.
A trio of well-respected American cancer research groups have recommended that females over 30 obtain HPV testing in addition to periodic Pap Smears. This advice is based upon the proven sensitivity of HPV testing in the detection of high-risk HPV viruses within cervical tissues that could progress into cancerous tumors.
The tacit inquiry underlying this controversy is essentially one of whether Pap Smears alone detect sufficient carcinoma of cervix development. An adjunct question centers upon whether or not HPV testing can adequately bridge this gap without causing unnecessary “treatment.”
One dual-screening study initially revealed that 25% more potentially carcinogenic cervical pathologies were detected than through exclusive Pap Smear testing. Five years later, dual-screened patients still exhibited a lower overall cervical cancer incidence. Both groups displayed comparable rates of high-risk cervical lesion development. This suggests that HPV testing alone does not detect many infections that might have resolved without treatment.
Cervical cancer experts currently involved in research updates have reviewed all the most current HPV and Pap Smear screening data. This collaborative effort was conducted for the purpose of devising more detailed information about the causes of cervical cancer and effective treatment of cervical cancer. All results gleaned to date strongly suggest that women past the age of 30 are well-advised to avail themselves of HPV testing benefits